Korea Stock Market Insights

Tag: Managed Stock

CCS (066790) Injunction Dismissal: A Positive Sign? Key Analysis for Investors!
Did you hear about the dismissal of the injunction against CCS (066790)? Is this a positive sign or the calm before the storm? This article provides clear guidance for investors by analyzing the implications of the dismissal, the current state of CCS, and the key information investors need to know.
What Happened with CCS?

On September 5, 2025, CCS announced that the court dismissed the injunction application filed against it (2025카합586). While this may appear as a resolution in the management dispute, an appeal has been filed, so it’s too early to be relieved.

Why is the Dismissal Important?

In the short term, the dismissal is positive as it reduces uncertainty surrounding the management dispute. However, CCS is still designated as a managed stock and trading remains suspended, with weak fundamentals. Therefore, it’s difficult to conclude that this dismissal alone solves CCS’s fundamental problems.

What’s Next for CCS?
- Ongoing Management Dispute: With the appeal filed, the management dispute is still ongoing.
- Deteriorating Fundamentals: Poor operating performance and weakened financial health pose serious fundamental problems.
- Delisting Risk: If the reasons for management designation are not resolved, CCS faces the risk of delisting.
What Should Investors Do?

Investors should not be swayed by short-term news and should carefully consider their investment decisions by closely monitoring CCS’s fundamental improvements, delisting possibility, and the final outcome of the management dispute. Hasty investments can lead to significant losses.
FAQ

Will the dismissal of the injunction positively impact CCS’s stock price?

It may have a positive impact in the short term, but it’s unlikely to lead to a sustained rise as CCS’s fundamental problems remain unresolved.

Is there a possibility of CCS being delisted?

If the reasons for management designation are not resolved, there is a possibility of delisting. Investors should proceed with caution.

Is it advisable to invest in CCS?

Currently, investing in CCS carries a very high risk. Careful investment decisions are crucial.
09/05/2025
Mirae Asset Dream SPAC 1 Faces Delisting Risk: Urgent Advice for Investors
Mirae Asset Dream SPAC 1 Faces Delisting Risk: Urgent Advice for Investors

Mirae Asset Dream SPAC 1 is facing a potential delisting crisis. The company must submit its merger preliminary review application by September 8, 2025, or risk being designated as a 관리종목 (managed stock), a designation that could ultimately lead to delisting. This article provides a crucial analysis of the situation, future outlook, and urgent advice for investors.
What Happened?

Mirae Asset Dream SPAC 1 is required to submit a merger preliminary review application by September 8, 2025. Failure to meet this deadline will result in the company being designated as a 관리종목 (managed stock) on September 9, 2025. If the situation isn’t rectified within one month, the company faces potential delisting from the exchange.

Why is this happening?

As a Special Purpose Acquisition Company (SPAC), Mirae Asset Dream SPAC 1’s sole purpose is to merge with a private company within a specific timeframe. The company has yet to identify a suitable merger target, putting it at risk of delisting. While they are considering targets in renewable energy, biopharmaceuticals, and IT convergence systems, no concrete merger process has begun.

What’s Next?

In the short term, the likelihood of being designated a 관리종목 is high, which will likely negatively impact investor sentiment and put downward pressure on the stock price. The medium to long-term outlook hinges on whether the company can submit the preliminary review application and successfully complete a merger. While a successful merger would resolve the crisis, the current uncertainty raises the possibility of delisting.

What Should Investors Do?
- Monitor the Application Submission: Closely monitor whether the company submits the preliminary review application by the September 8th deadline.
- If Submitted: Thoroughly analyze the proposed merger target before making any investment decisions.
- If Not Submitted: Consider strategies to recover your investment or minimize potential losses.
- Invest with Caution: Understand the inherent risks associated with SPAC investments, particularly the uncertainty surrounding mergers.
Frequently Asked Questions

What is a 관리종목 (managed stock)?

A 관리종목 is a designation given by the Korea Exchange to companies facing a high risk of delisting. This designation is intended to protect investors and comes with restrictions such as reduced trading volume and limited access to information.

What is a SPAC?

A SPAC (Special Purpose Acquisition Company) is a shell company created solely for the purpose of merging with or acquiring a private company and taking it public.

Why is Mirae Asset Dream SPAC 1 facing delisting risks?

The company is nearing its deadline to merge with a target company and has yet to identify a suitable candidate. Failure to complete a merger within the timeframe could lead to delisting.
09/01/2025
CCS (066790) Crisis: Management Disputes, Designated as a Managed Stock, and Now a Lawsuit?
CCS, Trapped in a Swamp of Setbacks… What Should Investors Do?

CCS (066790) is on the brink due to a series of negative events. A prolonged management dispute, designation as a managed stock, and a recent lawsuit against a major shareholder’s related party have heightened investor anxiety. This article analyzes the crisis surrounding CCS and suggests an action plan for investors.
What’s Happening?

Since late 2023, CCS has been embroiled in turmoil due to issues surrounding changes in major shareholders. Failure to obtain approval for the change of largest shareholder under the Broadcasting Act has resulted in corrective orders, administrative sanctions, and ongoing lawsuits. Furthermore, CCS has been designated as a managed stock due to inaccurate disclosures, and recently, a lawsuit demanding the return of shares has been filed against a related party of the major shareholder.

What are the root causes of these issues?

The fundamental problem is the management dispute. The failure to properly comply with legal procedures during the change of major shareholders has triggered a series of problems. This, coupled with poor performance in core businesses and deteriorating financial structure, has significantly undermined the company’s stability.

So, What’s Next?
- Increased Management Uncertainty: The ongoing management dispute and the outcome of the lawsuit will further increase uncertainty in the management environment.
- Higher Risk of Delisting: The lawsuit following the managed stock designation increases the likelihood of delisting.
- Worsening Financial Situation: Unexpected expenses, such as litigation costs, could further deteriorate the financial soundness of the company.
What Should Investors Do?

CCS currently carries a very high investment risk. New investments should be absolutely avoided, and existing investors must act cautiously, recognizing the low probability of recovering their investments. Investors need to continuously monitor relevant information, such as the outcome of the lawsuit and whether the managed stock designation is lifted, and consider the possibility of delisting in the worst-case scenario.
Frequently Asked Questions

Why was CCS designated as a managed stock?

CCS was designated as a managed stock on August 4, 2025, due to being identified as a company with inaccurate disclosures.

What is the recent lawsuit about?

It’s a lawsuit demanding the return of shares filed against a related party of the major shareholder.

Should I invest in CCS?

CCS currently carries a very high investment risk, and investment is not recommended. New investments, in particular, should be avoided at all costs.
08/21/2025